Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Empiric H. pylori therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best.

Literature DB >> 28819587

Empiric H. pylori therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best.

Yoshio Yamaoka^1,2, David Y Graham¹.

Abstract

Entities: Chemical Disease Species

Year: 2016 PMID： 28819587 PMCID： PMC5557030 DOI： 10.21037/tcr.2016.12.39

Source DB: PubMed Journal: Transl Cancer Res ISSN： 2218-676X Impact factor: 1.241

Keyword Cloud
References

× No keyword cloud information.

17 in total

1. Letter: the ethics of using inferior regimens in H. pylori randomised trials.

Authors: D Y Graham; L A Fischbach
Journal: Aliment Pharmacol Ther Date: 2012-04 Impact factor: 8.171

2. Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype.

Authors: David Y Graham
Journal: Helicobacter Date: 2015-11-27 Impact factor: 5.753

3. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors: P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal: Gut Date: 2016-10-05 Impact factor: 23.059

4. Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days.

Authors: Maria Pina Dore; Valentina Farina; Marianna Cuccu; Laura Mameli; Giovanni Massarelli; David Y Graham
Journal: Helicobacter Date: 2011-08 Impact factor: 5.753

5. Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection.

Authors: William M Geisler; Apurva Uniyal; Jeannette Y Lee; Shelly Y Lensing; Shacondra Johnson; Raymond C W Perry; Carmel M Kadrnka; Peter R Kerndt
Journal: N Engl J Med Date: 2015-12-24 Impact factor: 91.245

6. Helicobacter pylori eradication therapy research: Ethical issues and description of results.

Authors: David Y Graham
Journal: Clin Gastroenterol Hepatol Date: 2010-07-23 Impact factor: 11.382

7. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

Authors: Jyh-Ming Liou; Yu-Jen Fang; Chieh-Chang Chen; Ming-Jong Bair; Chi-Yang Chang; Yi-Chia Lee; Mei-Jyh Chen; Chien-Chuan Chen; Cheng-Hao Tseng; Yao-Chun Hsu; Ji-Yuh Lee; Tsung-Hua Yang; Jiing-Chyuan Luo; Chun-Chao Chang; Chi-Yi Chen; Po-Yueh Chen; Chia-Tung Shun; Wen-Feng Hsu; Wen-Hao Hu; Yen-Nien Chen; Bor-Shyang Sheu; Jaw-Town Lin; Jeng-Yih Wu; Emad M El-Omar; Ming-Shiang Wu
Journal: Lancet Date: 2016-10-18 Impact factor: 79.321